CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,790,000 | +2432.9% | 208,861 | +1114.3% | 0.39% | +3125.0% |
| Q2 2022 | $426,000 | -36.8% | 17,200 | -7.0% | 0.01% | -29.4% |
| Q4 2021 | $674,000 | +278.7% | 18,500 | +77.9% | 0.02% | +240.0% |
| Q3 2021 | $178,000 | +3460.0% | 10,400 | +1721.4% | 0.01% | – |
| Q2 2019 | $5,000 | -58.3% | 571 | -46.9% | 0.00% | -100.0% |
| Q4 2018 | $12,000 | -14.3% | 1,076 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | +7.7% | 1,076 | +9.5% | 0.00% | 0.0% |
| Q1 2018 | $13,000 | +225.0% | 983 | +96.6% | 0.00% | – |
| Q3 2017 | $4,000 | -73.3% | 500 | -68.8% | 0.00% | -100.0% |
| Q2 2017 | $15,000 | +1400.0% | 1,600 | +700.0% | 0.00% | – |
| Q1 2017 | $1,000 | -80.0% | 200 | -71.4% | 0.00% | -100.0% |
| Q4 2016 | $5,000 | +66.7% | 700 | +32.3% | 0.00% | – |
| Q3 2016 | $3,000 | -70.0% | 529 | -70.9% | 0.00% | -100.0% |
| Q3 2013 | $10,000 | – | 1,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |